These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 32657585)

  • 1. Structural Basis of Noscapine Activation for Tubulin Binding.
    Oliva MA; Prota AE; Rodríguez-Salarichs J; Bennani YL; Jiménez-Barbero J; Bargsten K; Canales Á; Steinmetz MO; Díaz JF
    J Med Chem; 2020 Aug; 63(15):8495-8501. PubMed ID: 32657585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rational design of biaryl pharmacophore inserted noscapine derivatives as potent tubulin binding anticancer agents.
    Santoshi S; Manchukonda NK; Suri C; Sharma M; Sridhar B; Joseph S; Lopus M; Kantevari S; Baitharu I; Naik PK
    J Comput Aided Mol Des; 2015 Mar; 29(3):249-70. PubMed ID: 25481458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rational design, synthesis and biological evaluations of amino-noscapine: a high affinity tubulin-binding noscapinoid.
    Naik PK; Chatterji BP; Vangapandu SN; Aneja R; Chandra R; Kanteveri S; Joshi HC
    J Comput Aided Mol Des; 2011 May; 25(5):443-54. PubMed ID: 21544622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elucidation of the Tubulin-targeted Mechanism of Action of 9-(3-pyridyl) Noscapine.
    Pradhan S; Mahaddalkar T; Choudhary S; Manhcukonda N; Nagireddy PR; Kantevari S; Lopus M
    Curr Top Med Chem; 2017; 17(22):2569-2574. PubMed ID: 28056737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new antiproliferative noscapine analogue: chemical synthesis and biological evaluation.
    Ghaly PE; Abou El-Magd RM; Churchill CD; Tuszynski JA; West FG
    Oncotarget; 2016 Jun; 7(26):40518-40530. PubMed ID: 27777381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Comprehension into Target Binding and Spatial Fingerprints of Noscapinoid Analogues as Inhibitors of Tubulin.
    Mandavi S; Verma SK; Banjare L; Dubey A; Bhatt R; Thareja S; Jain AK
    Med Chem; 2021; 17(6):611-622. PubMed ID: 31951171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and biological evaluation of a novel tubulin inhibitor 7a3 targeting the colchicine binding site.
    Lai Q; Wang Y; Wang R; Lai W; Tang L; Tao Y; Liu Y; Zhang R; Huang L; Xiang H; Zeng S; Gou L; Chen H; Yao Y; Yang J
    Eur J Med Chem; 2018 Aug; 156():162-179. PubMed ID: 30006162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rational design, synthesis, and biological evaluation of third generation α-noscapine analogues as potent tubulin binding anti-cancer agents.
    Manchukonda NK; Naik PK; Santoshi S; Lopus M; Joseph S; Sridhar B; Kantevari S
    PLoS One; 2013; 8(10):e77970. PubMed ID: 24205049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tubulin binding, protein-bound conformation in solution, and antimitotic cellular profiling of noscapine and its derivatives.
    Bennani YL; Gu W; Canales A; Díaz FJ; Eustace BK; Hoover RR; Jiménez-Barbero J; Nezami A; Wang T
    J Med Chem; 2012 Mar; 55(5):1920-5. PubMed ID: 22320354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insights into the structure and tubulin-targeted anticancer potential of N-(3-bromobenzyl) noscapine.
    Cheriyamundath S; Mahaddalkar T; Reddy Nagireddy PK; Sridhar B; Kantevari S; Lopus M
    Pharmacol Rep; 2019 Feb; 71(1):48-53. PubMed ID: 30465924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The novel microtubule-destabilizing drug BAL27862 binds to the colchicine site of tubulin with distinct effects on microtubule organization.
    Prota AE; Danel F; Bachmann F; Bargsten K; Buey RM; Pohlmann J; Reinelt S; Lane H; Steinmetz MO
    J Mol Biol; 2014 Apr; 426(8):1848-60. PubMed ID: 24530796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of noscapine's localization and interaction with the tubulin-α/β heterodimer.
    Alisaraie L; Tuszynski JA
    Chem Biol Drug Des; 2011 Oct; 78(4):535-46. PubMed ID: 21781284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular modelling and competition binding study of Br-noscapine and colchicine provide insight into noscapinoid-tubulin binding site.
    Naik PK; Santoshi S; Rai A; Joshi HC
    J Mol Graph Model; 2011 Jun; 29(7):947-55. PubMed ID: 21530342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of microtubule-interfering halogenated noscapine analogs that perturb mitosis in cancer cells followed by cell death.
    Aneja R; Vangapandu SN; Lopus M; Viswesarappa VG; Dhiman N; Verma A; Chandra R; Panda D; Joshi HC
    Biochem Pharmacol; 2006 Aug; 72(4):415-26. PubMed ID: 16780803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In silico inspired design and synthesis of a novel tubulin-binding anti-cancer drug: folate conjugated noscapine (Targetin).
    Naik PK; Lopus M; Aneja R; Vangapandu SN; Joshi HC
    J Comput Aided Mol Des; 2012 Feb; 26(2):233-47. PubMed ID: 22170255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rational design of novel N-alkyl amine analogues of noscapine, their chemical synthesis and cellular activity as potent anticancer agents.
    Meher RK; Pragyandipta P; Pedapati RK; Nagireddy PKR; Kantevari S; Nayek AK; Naik PK
    Chem Biol Drug Des; 2021 Sep; 98(3):445-465. PubMed ID: 34051055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure of a benzylidene derivative of 9(10H)-anthracenone in complex with tubulin provides a rationale for drug design.
    Cheng J; Wu Y; Wang Y; Wang C; Wang Y; Wu C; Zeng S; Yu Y; Chen Q
    Biochem Biophys Res Commun; 2018 Jan; 495(1):185-188. PubMed ID: 29102632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and synthesis of novel 5-(4-chlorophenyl)furan derivatives with inhibitory activity on tubulin polymerization.
    Moussa SA; A Osman EE; Eid NM; Abou-Seri SM; El Moghazy SM
    Future Med Chem; 2018 Aug; 10(16):1907-1924. PubMed ID: 29966433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discover 4β-NH-(6-aminoindole)-4-desoxy-podophyllotoxin with nanomolar-potency antitumor activity by improving the tubulin binding affinity on the basis of a potential binding site nearby colchicine domain.
    Zhao W; He L; Xiang TL; Tang YJ
    Eur J Med Chem; 2019 May; 170():73-86. PubMed ID: 30878833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The compound millepachine and its derivatives inhibit tubulin polymerization by irreversibly binding to the colchicine-binding site in β-tubulin.
    Yang J; Yan W; Yu Y; Wang Y; Yang T; Xue L; Yuan X; Long C; Liu Z; Chen X; Hu M; Zheng L; Qiu Q; Pei H; Li D; Wang F; Bai P; Wen J; Ye H; Chen L
    J Biol Chem; 2018 Jun; 293(24):9461-9472. PubMed ID: 29691282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.